skip to the content
References: Avastin MoA
- Hicklin DJ, Ellis LM. J Clin Oncol 2005;23:1011–27.
- Presta LG, Chen H, O'Connor SJ, et al. Cancer Res 1997;57:4593–9.
- Jain RK, Duda DG, Clark JW, Loeffler JS. Nat Clin Pract Oncol 2006;3:24–40.
- Baka S, Clamp AR, Jayson GC. Expert Opin Ther Targets 2006;10:867–76.
- Yuan F, Chen Y, Dellian M, Safabakhsh N, Ferrara N, Jain RK. Proc Natl Acad Sci USA 1996;93:14765–70.
- Willett CG, Boucher Y, di Tomaso TE, et al. Nat Med 2004;10:145–7.
- Lee CG, Heijn M, di Tomaso TE et al. Cancer Res 2000;60:5565–70.
- Gerber HP, Ferrara N. Cancer Res 2005;65:671–80.
- Borgström P, Hillan KJ, Sriramarao P, Ferrara N. Cancer Res 1996;56:4032–9.
- Borgström P, Bourdon MA, Hillan KJ, Sriramarao P, Ferrara N. Prostate 1998;35:1–10.
- Jain RK. Nat Med 2001;7:987–9.
- Jain RK. Science 2005;307:58–62.
- Warren RS, Yuan H, Matli MR, Gillett NA, Ferrara N. J Clin Invest 1995;95:1789–97.
- Huang J, Frischer JS, Serur A, et al. Proc Natl Acad Sci USA 2003;100:7785–90.
- Avastin Summary of Product Characteristics. Available at: http://www.emea.europa.eu/humandocs/PDFs/EPAR/avastin/emea-combined-h582en.pdf
- Gray R, Bhattacharya S, Bowden C, Miller K, Comis RL. J Clin Oncol 2009;27:4966–72.
- Reck M, von Pawel J, Zatloukal P, et al. J Clin Oncol 2009;27:1227–34.
- Sandler A, Gray R, Perry MC, et al. N Engl J Med 2006;355:2542–50.
- Escudier B, Pluzanska A, Koralewski P, et al. Lancet 2007;370:2103–11.
- Hurwitz H, Fehrenbacher L, Novotny W, et al. N Engl J Med 2004;350:2335–42.
- Giantonio BJ, Catalano PJ, Meropol NJ, et al. J Clin Oncol 2007;25:1539–44.
- Kerbel RS. Science 2006;312:1171–5.
- Bergers G, Benjamin LE. Nat Rev Cancer 2003;3:401–10.
- Pivot X, Verma S, Thomssen C, et al. J Clin Oncol 2009;27(May 20 Suppl.):64s (Abstract 1094 and associated poster presentation).
- Miles DW, Chan A, Romieu G, et al. J Clin Oncol 2008;26(June 20 Suppl.):1008s (Abstract LBA1011).
- Grothey A, Hedrick EE, Mass RD, et al. J Clin Oncol 2008;26:183–9.